The topic is short and compact
Feasibility is determined by raw materials, regulatory requirements, equipment, and packaging, not by the formulation idea.
On the critical path, only a few blocks are truly fixed, especially the twelve-week stability testing and the packaging tooling.
A trend launch is more likely to fail due to a lack of replenishment capability than due to the deadline of the initial batch.
A feasibility check does not need a formulation, but four answers. First: Is the active ingredient or core material available in European quality, with complete documentation and in the required quantity, and not as a sample, but as a batch. Second: Is the claim that makes the trend attractive in the first place permissible within the European framework. Third: Can the existing equipment manufacture the texture, or does it require a process that the partner does not possess. Fourth: Does the packaging material exist as a standard, or does it require its own tooling.
If one of these four questions is negative, the trend is not impossible, but it is not fast. That is the really important distinction. A project that continues with the original deadline despite a negative answer produces the delay that nobody can explain later.
Raw material: batch availability and documentation, not sample availability.
Regulatory: Assess the permissibility of the central claim in advance.
Equipment: Process capability for the planned texture and viscosity.
Packaging material: Standard or tooling, with its own minimum order quantity and delivery time.
A structured approach for this preliminary check is described in Trends auf Machbarkeit prüfen, the classification of current topics in Trends 2026 und ihre Umsetzbarkeit.
The four knock-out questions before committing development budget
A feasibility check does not need a formulation, but four answers. First: Is the active ingredient or core material available in European quality, with complete documentation and in the required quantity, and not as a sample, but as a batch. Second: Is the claim that makes the trend attractive in the first place permissible within the European framework. Third: Can the existing equipment manufacture the texture, or does it require a process that the partner does not possess. Fourth: Does the packaging material exist as a standard, or does it require its own tooling.
If one of these four questions is negative, the trend is not impossible, but it is not fast. That is the really important distinction. A project that continues with the original deadline despite a negative answer produces the delay that nobody can explain later.
Raw material: batch availability and documentation, not sample availability.
Regulatory: Assess the permissibility of the central claim in advance.
Equipment: Process capability for the planned texture and viscosity.
Packaging material: Standard or tooling, with its own minimum order quantity and delivery time.
A structured approach for this preliminary check is described in Trends auf Machbarkeit prüfen, the classification of current topics in Trends 2026 und ihre Umsetzbarkeit.
What is actually fixed on the critical path
Most projects are slower than necessary because blocks are treated as fixed when they are not, and because the few genuinely fixed blocks are started too late. There are essentially three things that are truly fixed: the accelerated stability test over twelve weeks, the procurement of packaging material with its own tooling, and the safety assessment including notification before placing on the market.
These blocks cannot be negotiated, but they can be started early. The most expensive mistake is changing the packaging after the testing phase has started, because the stability test depends on the combination of formulation and packaging material and starts over with a new packaging material.
Twelve weeks of accelerated stability, cannot be shortened.
Order tooling-dependent packaging materials with long lead times early.
Schedule safety assessment and notification before placing on the market.
Freeze packaging before the start of testing, otherwise the test restarts.
Which weeks in the project are actually lost and where they can be recovered is described in detail in Shortening Time-to-Market.
What can be parallelized without creating risk
In addition to the fixed blocks, there is a significant part of the project that does not have to run sequentially. Packaging selection and design development can run parallel to the formulation development, as long as the material decision is made early. Also, the preparation of the documentation, the clarification of the claims, and the supplier qualification do not tie up laboratory time.
Parallelization only becomes risky at one point: during the printing of the packaging. Printed folding boxes and labels should only be released once the claims and safety assessment are finalized. Everything before that is preparation, everything after is waste.
Design and packaging selection parallel to formulation development.
Build up claims and evidence parallel to the testing phase.
Bring supplier qualification forward; it is rarely assigned a time-critical status.
Print release only after final claims and safety assessment.
Where projects typically fail anyway is shown in Avoiding launch delays; how deadlines can be made permanently predictable in predictable launch dates.
Viral demand is a capacity problem, not a marketing success
The most common damage to trend products does not occur at the launch, but four weeks later. The initial batch is deliberately calculated to be small, demand exceeds it, and subsequent production requires raw material lead time, plant capacity, and packaging materials again. In this gap, the brand loses exactly the attention it paid for.
This can be prevented with two decisions before the launch. First, a binding statement from the manufacturer on the replenishment time of the second batch, including raw material lead time. Second, a raw material reservation for the probable reorder quantity, even if it initially ties up capital. Both are significantly cheaper than an out-of-stock product with no date.
Document the replenishment time of the second batch in writing before the launch.
Reserve raw materials for the expected reorder.
Order packaging materials in tiers to cushion tooling and printing lead times.
Check minimum quantities per variant before the number of variants increases.
The planning required for this is detailed in Plan subsequent production and Secure delivery capability, the quantity logic in Minimum order quantities.
Clinical-style positioning: what needs to be proven
Many trendy products adopt the visual language of dermatology: sober packaging, percentages, references to studies, a tone that sounds like a clinical practice. This positioning works in the market, but increases the requirements for supporting evidence. The more clinical a product appears, the more likely a statement is read as an efficacy claim and must be proven accordingly.
The crucial factor is the separation of positioning and claims. An objective appearance can be freely designed. A percentage on the front, an efficacy figure, or a reference to a study are not, unless they refer to the finished product. Raw material studies generally do not support a product claim.
Objective design yes, mechanistic efficacy claims only with proof.
Percentages only if concentration and reference are clear.
Provide evidence at the product level, not at the raw material level.
Have claims reviewed before print release.
Which claims are viable under Regulation (EU) 655/2013 is detailed in EU cosmetic claims.
The fastest path is often the narrowest compass
When the deadline is tight, the most effective measure is no longer more speed, but less scope. A starting line-up with one variant, one pack size and one standard packaging material regularly reaches the market months earlier than a launch with three variants, because each variant generates its own testing, its own minimum quantity and its own packaging material order.
Where speed is crucial without development risk, an existing basic formulation that is adapted instead of newly developed can also be considered. The difference is not the quality, but the degree of freedom: less individuality, but a significantly shorter and more predictable path.
One variant and one pack size at the start, expansion based on demand.
Standard packaging material instead of special tooling when the deadline is leading.
Check adapted basic formulation if individuality is not decisive for purchase.
Evaluate samples before budget approval to avoid late corrections.
When an adapted base is the right choice is explained in the Private Label Guide; why samples save time before approval, samples before budget approval.
Whether a trend project is resilient is shown by the quality of the commitments, not by the commitment itself. A partner who names a date without reservation before raw materials and packaging materials have been clarified is naming a hope. A statement only becomes resilient when it discloses the assumptions under which it applies.
Therefore, demand a written feasibility statement on the four knock-out questions, a schedule with designated fixed blocks and named assumptions, as well as a statement on the replenishment time of the follow-up batch. These three points reliably separate a plannable launch from one that becomes noticeable in the fourth month.
Written feasibility statement on raw material, regulatory affairs, equipment, and packaging material.
Schedule with marked fixed blocks and disclosed assumptions.
Replenishment time and minimum quantity of the second batch.
Clear assignment of who is responsible for safety assessment and notification.
As a development and manufacturing partner, Labtree works in this order: first feasibility and timeframe, then formulation in its own laboratory, then samples and testing. What realistically takes how long in which project phase is shown in the development timeline, the scope of testing in stability and safety testing.
More useful links
FAQ
How quickly can a trend product realistically be launched?
With an adapted basic formula and standard packaging, around four to six months is realistic; for a new development, it is more like six to nine months. The block that cannot be shortened is the accelerated stability testing over twelve weeks. What can be shortened above all is the lead-up to this, by finalizing the packaging and product claims early on.
How can I recognize early on that a trend is not feasible to produce?
Four questions: Is the raw material available in European quality as a batch, is the central claim permissible, can the facility manufacture the texture, and does the packaging material exist as a standard. If one of these is negative, the project is not impossible, but it is not fast. This check does not require a formulation and takes about two weeks.
What happens if the packaging is changed in the middle of the project?
The stability testing starts from scratch because it depends on the combination of formulation and packaging material. A change after the start of testing therefore regularly costs an additional twelve weeks. The packaging decision should therefore be bindingly frozen before the start of the testing phase.
How do I prevent a viral product from selling out?
Through two decisions before the launch: a written statement from the manufacturer on the replenishment time of the second batch including raw material lead time, and a raw material reservation for the likely reorder quantity. Both tie up capital, but are cheaper than a sold-out product with no delivery date.
Can a product look clinical and advertise with studies?
The creative design is free. Conversely, an effectiveness rating, a percentage, or a reference to a study must relate to the finished product. Raw material studies generally do not support a product claim. Claims should be checked before printing approval; otherwise, printed packaging becomes waste.
Is a customized base formulation worse than a new development?
No, the difference lies in the degree of freedom, not in the quality. A customized base allows for less individuality in terms of texture, combination of active ingredients, and fragrance, but it leads to the market much faster and more predictably. If individuality is not a purchasing factor, it is the more rational choice when deadlines are tight.
